Invectys
Invectys

Invectys Information

Contact top employees from Invectys

Summary

Invectys is a private company that has been in the industry for 15 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the President & CEO is occupied by Praveen Tyle. Its headquarters is located at Houston, Texas, USA. The number of employees ranges from 25 to 100. The annual revenue of Invectys varies between 100K and 5.0M. Total funding of the company - $44.6M. To connect with Invectys employee register on SignalHire.

Organization Website

invectys.com

Social Links

linkedIn

Industries

Headquarters Location

12, Rue Jean-Antoine de Baïf, Paris, Île-de-France, 75013 FR

Employees Size

10-50 employees

Specialties

oncology, immunotherapy, biotech

SIC Code

2836, 2834

DMA Code

Greater Houston

Founded

2010

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2008Public
Company
100 - 250 66.4M $290.6M
2016Privately
Held
1 - 25 5M $115.3M
2001Public
Company
25 - 100 14M $379.4M
2008Privately
Held
250 - 500 40.9M $923.3M

Employees Turnover 3 quarter 2025

Number of employees switched from or switched to
arrow
Total number all of employee turnover
Length of Employment
arrow
Employee tenure at Invectys shows a diverse range of experience levels:
5% have been with the company for less than 1 year10% for 1–2 years10% for 3–4 years30% for 5–7 years15% for 8–10 years30% have over 11 years of service at Invectys
Ex-employees positions
In Company
In New Company
Contact top employees from Invectys
Qi Melissa Yang
Vice President, Scientific Affairs
View
Carlos Romero
Senior Director / Global Head of Quality
View
Tania Rodríguez
Associate Director/Principal Scientist
View
Amber Minter
Office Manager/Accounting
View
Jake Kushner MD
Chief Executive Officer
View

FAQ

Invectys operates in the Biotech industries. More details can be found on the official website: invectys.com.
The headquarters of Invectys are located in Paris, France.
The current CEO of Invectys is Praveen Tyle
Invectys currently employs 10-50 people.
Invectys's revenue is approximately 4.2M.
Well-known competitors of Invectys include CytomX Therapeutics, Immune-Onc Therapeutics, AVEO Oncology and Immunocore.
BACK TO TOP